Exelixis, Inc. (NASDAQ:EXEL) closed its last session at $8.15 with the change of +0.12%. The market capitalization of the company is $1.86B with an average Volume of 6.09 million shares. The stock currently has its 52-Week High range of $8.21 and 52-week low range of $3.55. . The stock traded total quantity of 7.07 million shares.
For the current Fiscal Quarter, 5 analysts have given an average earnings per share forecast of $-0.27. The Low Earnings per share estimate of the current Quarter is $-0.29 and High Estimate is set at $-0.21 according to these Analysts opinions. The Previous Year EPS of this Quarter is $-0.22.
According to 5 analysts, an average sales Estimate of the current Fiscal quarter is $16.76M. The lower sales estimate is $10.50M and higher sales estimate is $27.46M according to these Analysts thoughts.
The Company currently has Highest Price Target of $10 and Lowest Price Target of $5. It has Median Price Targets of $8. Mean price target is set at $7.67 after consensus analysis of 3 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 3 analysts have assigned this stock as Strong Buy where 1 assigned Buy, 1 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.
Medivation, Inc. (NASDAQ:MDVN) ended its last trade at $62.10 with the move of -1.02%. The company has market value of $10.22B with the total traded volume of 1.39 million. The stock currently has its 52-Week top value of $62.98 and 52-week down value of $26.41. The price to book (P/B) ratio of the company is 11.47. Its previous closing price was recorded at $62.74.
For the current Fiscal Quarter, 15 analysts have given an Average earnings estimate of $0.29 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $0.23 while High Estimate is $0.36. The Previous Year EPS of this Quarter is $0.29.
According to 17 analysts, an Average Revenue Estimate of the current Fiscal quarter is $221.20M. According to them, the Low Revenue estimate is $205.75M and High Revenue estimate is $238.85M.
The Company currently has High Price Target of $76. The Low and Mean Price Targets are $40 and $64.65 respectively. These price targets are set after consensus analysis of 17 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 6 analysts have given this stock as Strong Buy where 5 issued Buy, 6 analysts think that it’s a Hold, 0 told Underperform and0 assigned Sell rating.